Sleep hormone may ward off Post-Surgery delirium in seniors
NCT ID NCT03785158
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether giving melatonin, a natural sleep hormone, could prevent delirium (sudden confusion) in elderly patients after major non-cardiac surgery. Researchers enrolled 88 patients aged 65 and older across multiple hospitals. The goal was to see if a larger trial is possible, not yet to prove melatonin works.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Melatonin (liquid supplement)
- What this could lead to
- If it works, this could point toward a simple, low-cost way to prevent delirium in older patients after major surgery.
- What could go wrong
- This was only a small pilot study testing feasibility, not effectiveness. The results may not show a clear benefit, and larger trials are needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
88 people
The number who actually took part.
- Started
-
Sep 2021
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \>65 years * having a major non-cardiac surgery (which involve major vascular, thoracic, orthopedic, gynecological, otolaryngeal, general and gastrointestinal surgeries) with an expected hospital stay of 2 days or more, and * ability to provide informed consent Exclusion Criteria: * active delirium or dementia * ongoing melatonin treatment * unable to take oral medications * planned postoperative ventilation * previous study participation * allergy to melatonin * hepatic impairment defined as alanine aminotransferase greater than 500 IU/L * previous liver transplant or liver cirrhosis of Child-Pugh classes B and C * not willing to participate * language barrier
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Major non-cardiac surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hamilton Health Sciences-Juravinski Hospital Location
Hamilton, Ontario, L8V 1C3, Canada
-
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield surgery patients from sepsis and lung failure?
- Personalized blood pressure during surgery may cut heart and kidney risks
- Ear-Zap may speed Post-Surgery waking and cut depression risk
- Exercise hormone irisin may shield elderly brains from Post-Surgery confusion
- Can smart alerts stop Post-Surgery confusion in Memory-Impaired patients?
- New pain block after heart surgery aims to cut opioid use